Department of Nutrition, Faculty of Medicine, University of Chile, Santiago, Chile.
Department of Nutrition, Faculty of Medicine, University of Chile, Santiago, Chile; Lipid Center, Institute of Nutrition and Food Technology, University of Chile, Santiago, Chile.
Free Radic Biol Med. 2018 Oct;126:313-321. doi: 10.1016/j.freeradbiomed.2018.08.030. Epub 2018 Aug 25.
Enhanced iron levels in liver are associated with oxidative stress development and damage with increased fat accumulation. The aim of this work was to assess the hypothesis that antioxidant-rich extra virgin olive oil (AR-EVOO) counteracts iron-rich diet (IRD)-induced oxidative stress hindering hepatic steatosis. Male Wistar rats were fed and IRD (200 mg iron/kg diet) versus a control diet (CD; 50 mg iron/kg diet) with alternate AR-EVOO supplementation (100 mg/day) for 21 days. IRD induced liver steatosis and oxidative stress (higher levels of protein oxidation and lipid peroxidation with glutathione depletion), mitochondrial dysfunction (decreased citrate synthase and complex I and II activities) and loss of polyunsaturated fatty acids (PUFAs), with a drastic enhancement in the sterol regulatory element-binding protein-1c (SREBP-1c)/peroxisome proliferator-activated receptor-α (PPAR-α) ratio upregulating the expression of lipogenic enzymes (acetyl-CoA carboxylase, fatty acid (FA) synthase and stearoyl desaturase 2) and downregulating those involved in FA oxidation (carnitine palmitoyl transferase and acyl-CoA oxidase) over values in the CD group. IRD also upregulated nuclear factor erythroid 2-related factor 2 (Nrf2) and its target genes. AR-EVOO supplementation alone did not modify the studied parameters, however, IRD combined with AR-EVOO administration returned IRD-induced changes to baseline levels of the CD group. It is concluded that IRD-induced non-alcoholic fatty liver disease (NAFLD) is prevented by AR-EVOO supplementation, which might be related to the protective effects of its components such as hydroxytyrosol, oleic acid, tocopherols and/or PUFAs, thus representing a suitable anti-steatotic strategy to avoid progression into more severe stages of the disease, underlying NAFLD associated with iron overloading pathologies or obesity.
肝脏中铁水平升高与氧化应激的发展和损伤有关,同时伴随着脂肪堆积的增加。本研究旨在评估以下假设,即富含抗氧化剂的特级初榨橄榄油(AR-EVOO)可以抵抗富含铁的饮食(IRD)引起的氧化应激,从而阻止肝脂肪变性。雄性 Wistar 大鼠分别用富含铁的饮食(200mg 铁/千克饮食)和对照饮食(50mg 铁/千克饮食)喂养,并交替补充 AR-EVOO(100mg/天)21 天。富含铁的饮食导致肝脏脂肪变性和氧化应激(蛋白质氧化和脂质过氧化水平升高,谷胱甘肽耗竭)、线粒体功能障碍(柠檬酸合酶和复合物 I 和 II 活性降低)和多不饱和脂肪酸(PUFAs)丢失,固醇调节元件结合蛋白-1c(SREBP-1c)/过氧化物酶体增殖物激活受体-α(PPAR-α)比值急剧升高,上调脂肪生成酶(乙酰辅酶 A 羧化酶、脂肪酸合成酶和硬脂酰去饱和酶 2)的表达,下调脂肪酸氧化酶(肉碱棕榈酰转移酶和酰基辅酶 A 氧化酶)的表达,与对照饮食组相比,这些酶的表达水平降低。富含铁的饮食还上调了核因子红细胞 2 相关因子 2(Nrf2)及其靶基因。单独补充 AR-EVOO 并没有改变研究参数,然而,富含铁的饮食与 AR-EVOO 联合使用使富含铁的饮食引起的变化恢复到对照饮食组的基线水平。综上所述,AR-EVOO 补充可预防富含铁的饮食引起的非酒精性脂肪性肝病(NAFLD),这可能与 AR-EVOO 成分如羟基酪醇、油酸、生育酚和/或 PUFAs 的保护作用有关,因此代表了一种合适的抗脂肪变性策略,可以避免疾病进展到更严重的阶段,从而避免与铁过载病理或肥胖相关的 NAFLD 发生。